Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Current Deferred Revenue: 2017-2025

Historic Current Deferred Revenue for cbdMD (YCBD) over the last 3 years, with Sep 2025 value amounting to $506,289.

  • cbdMD's Current Deferred Revenue rose 0.60% to $506,289 in Q3 2025 from the same period last year, while for Sep 2025 it was $506,289, marking a year-over-year increase of 0.60%. This contributed to the annual value of $506,289 for FY2025, which is 0.60% up from last year.
  • Latest data reveals that cbdMD reported Current Deferred Revenue of $506,289 as of Q3 2025, which was down 0.57% from $509,198 recorded in Q2 2025.
  • In the past 5 years, cbdMD's Current Deferred Revenue ranged from a high of $557,353 in Q1 2025 and a low of $755 during Q2 2021.
  • Its 3-year average for Current Deferred Revenue is $475,912, with a median of $507,744 in 2025.
  • As far as peak fluctuations go, cbdMD's Current Deferred Revenue surged by 171.67% in 2024, and later fell by 7.43% in 2025.
  • Quarterly analysis of 4 years shows cbdMD's Current Deferred Revenue stood at $755 in 2021, then reached $185,246 in 2023, then spiked by 171.67% to $527,438 in 2024, then increased by 0.60% to $506,289 in 2025.
  • Its Current Deferred Revenue was $506,289 in Q3 2025, compared to $509,198 in Q2 2025 and $557,353 in Q1 2025.